旅行疫苗的全球市场规模:各产品，各用途，各地区，范围及预测

旅行疫苗市场规模及预测

2024年旅行疫苗市场规模为42.8亿美元，预计2024年至2031年复合年增长率为11.50%，2031年达到94.7亿美元。旅行相关疾病发生率的增加预计将推动市场成长。旅行往往涉及很高的健康风险，尤其是传染病。因此，旅行相关疾病发生率的增加将导致全球旅行疫苗市场的投资增加，以实现更有效的疫苗开发。该报告对全球旅行疫苗市场进行了全面评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面分析。

旅行疫苗的全球市场推动因素

旅行疫苗市场的市场推动因素受到多种因素的影响。

海外旅行增加：

全球化和可支配收入的增加导致越来越多的人出国出差、休閒和接受教育。为了避免某些地区可能流行的疾病，旅行疫苗的需求量很大。

政府要求：

许多国家要求旅行者在进入该国之前接种某些疾病的疫苗。现行立法的修订或在强制疫苗接种清单中增加额外疫苗接种可能会对市场产生影响。

意识不断提高：

旅客对免疫接种等预防性医疗保健价值的认识不断提高，推动了旅游疫苗接种的需求。

新兴传染病：

COVID-19 病毒、伊波拉出血热和寨卡病毒等传染病的传播可能会严重影响旅行模式，需要特定的免疫接种，并且对这些疫苗的需求不断增加。

技术开发：

疫苗技术的发展可能有利于市场，包括透过提高疫苗接种率和患者依从性来开发更有效或更持久的疫苗。

医疗支出增加：

随着富裕国家和发展中国家的医疗保健成本上升，更多的人将能够购买旅游疫苗，从而扩大市场。

旅行者的兴趣日益增加：

由于担心自己的健康和安全，越来越多的人正在寻求疫苗接种和其他预防性治疗，尤其是在前往流行或地方性疾病流行的地区时。

游客人口统计：

市场动态可能受到人口统计变数的影响，例如人口老化和来自疾病高发地区的旅行者数量的增加。

旅游业的成长：

随着越来越多的人访问新目的地并参加各种活动，包括探险旅游和医疗旅游在内的旅游业的扩张推动了旅行疫苗的需求。

公共卫生措施：

政府机构和国际卫生组织为促进旅客接种疫苗而进行的公共卫生运动和措施可以对市场产生积极影响。

全球旅行疫苗市场的阻碍因素

有几个因素可能对旅行疫苗市场构成限制和课题。

昂贵：

旅行疫苗接种可能很昂贵，特别是对于前往需要多次疫苗接种的多个地点的人来说。没有经济能力的旅客可能会因疫苗接种和体检的费用而感到害怕。

易于取得：

旅行疫苗可能并非到处都能买到。在某些地区，由于前往提供全面旅行免疫服务的旅行专用诊所或医疗保健提供者的机会有限，免疫率可能会降低。

旅行者对疫苗犹豫不决

旅行者对疫苗接种的犹豫：旅行者对疫苗接种的犹豫以及一般免疫模式可能会影响旅行者的疫苗接种率。有些人因为担心疫苗的有效性、安全性或必要性而选择不接受建议的免疫接种。

物流困难：

旅行者，尤其是行程复杂或出发前时间有限的旅行者，可能会发现很难获得旅行疫苗，而在一段时间内多次接种疫苗可能会遇到困难。

复杂的行程：

对于行程复杂的旅行者，包括前往需要接种各种疫苗的多个地点的旅行者，可能很难管理和遵守所有规定的疫苗接种，导致疫苗接种可能无法提供或可能不充分。

短途旅行：

休短假或提早下班的人可能会优先考虑其他与旅行相关的计划，而不是接种疫苗，特别是如果他们认为自己患病的风险较低。

监理墙：

如果旅客无法及时获得必要的疫苗，可能会遇到困难。监管障碍的例子包括签证要求和基于疫苗接种状况的入境限制。

缺乏教育与意识：

免疫接种的需求可能较低，因为旅客不了解免疫接种的价值以及特定地点疫苗可预防疾病的风险。

竞争优先：

如果旅客认为自己感染疫苗可预防疾病的机会很低，或者没有足够的时间或金钱进行旅行前治疗，那么接种疫苗可能比其他旅行选择更可取。

传染病爆发与旅行问题：

传染病的爆发增加了对某些旅行疫苗的需求，但也可能导致人们完全避免旅行，而在此期间对旅行疫苗的需求通常会减少。

目录

第1章 全球旅行疫苗市场简介

• 市场概要
• 调查范围
• 前提条件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的调查手法

• 资料探勘
• 验证
• 第一手资料
• 资料来源一览

第4章 全球旅行疫苗市场展望

• 概要
• 市场动态
• 促进因素
• 阻碍因素
• 机会
• 波特的五力分析
• 价值链分析

第5章 旅行疫苗的全球市场:各产品

• 脑膜炎疫苗
• B型肝炎疫苗
• A型肝炎疫苗
• 其他

第6章 旅行疫苗的全球市场:各用途

• 国内旅游
• 海外旅行

第7章 旅行疫苗的全球市场:各地区

• 北美
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 德国
• 英国
• 法国
• 其他欧洲
• 亚太地区
• 中国
• 日本
• 印度
• 其他亚太地区
• 全球其他地区
• 南美
• 中东·非洲

第8章 全球旅行疫苗市场:竞争情形

• 概要
• 各公司的市场排行榜
• 主要的开发策略

第9章 企业简介

• Pfizer
• Sanofi
• GlaxoSmithKline
• Merck
• AstraZeneca
• Abbott
• Roche
• Takeda Pharmaceutical
• Valeant Pharmaceuticals
• SK Chemicals
• Hualan Biological Engineering
• Serum Institute of India

第10章 附录

• 相关调查

Travel Vaccines Market Size And Forecast

Travel Vaccines Market size was valued at USD 4.28 Billion in 2024 and is projected to reach USD 9.47 Billion by 2031, growing at a CAGR of 11.50% from 2024 to 2031. Increased incidence of travel-related diseases is expected to drive market growth. Traveling is often associated with higher health risks, especially regarding infectious diseases. Thus, the rising incidence of travel-related diseases will lead to more investments in the global Travel Vaccines Market for the development of more effective vaccines. The Global Travel Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Travel Vaccines Market Drivers

The market drivers for the Travel Vaccines Market can be influenced by various factors. These may include:

Growing International Travel:

More individuals are going abroad for business, pleasure, and education as a result of globalisation and increased disposable incomes. In order to avoid diseases that might be common in certain locations, this fuels the demand for travel vaccinations.

Government Requirements:

A number of nations have laws requiring visitors to be immunised against specific diseases before to entry. The market may be impacted by modifications to existing laws or by the inclusion of additional vaccinations on the list of mandatory shots.

Growing Awareness:

The demand for travel vaccinations is being driven by travellers' increasing awareness of the value of preventive healthcare measures, such as vaccinations.

Emerging Infectious Diseases:

Travel patterns can be greatly impacted by the spread of infectious diseases like the COVID-19 virus, Ebola, or Zika virus, which also makes certain vaccinations necessary, which drives up demand for those vaccines.

Technological Developments:

By increasing vaccination uptake rates and patient compliance, developments in vaccine technology, such as the creation of more potent or long-lasting vaccinations, can benefit the market.

Increasing Healthcare Expenditure:

As healthcare costs rise in rich and developing nations alike, more people will be able to buy travel vaccinations, which will lead to an expansion of the market.

Growing Traveller Concerns:

People are seeking vaccinations and other preventive treatments due to worries about their health and safety when travelling, particularly to areas where endemic diseases or outbreaks are occurring.

Traveller Demographics:

The market dynamics may be impacted by demographic variables like an ageing population or a rise in the number of visitors from areas with higher rates of disease prevalence.

Growth of the tourist Industry:

As more people travel to new places and partake in a variety of activities, the need for travel vaccinations is being driven by the tourist industry's expansion, which includes adventure and medical tourism.

Public Health efforts:

Through government agencies or international health organisations, public health campaigns and efforts that promote traveller vaccination can have a positive impact on the market.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Travel Vaccines Market Restraints

Several factors can act as restraints or challenges for the Travel Vaccines Market. These may include:

Expensive:

Vaccinations against travel can be costly, particularly for people who are visiting several places that require several shots. Some travellers may be discouraged by the cost of vaccinations and consultation costs, especially those with little funds.

Limited Accessibility:

Vaccines for travel are not always readily available everywhere. Immunisation rates may be hampered in some areas by restricted access to specialty travel clinics or medical institutions that provide a comprehensive selection of travel vaccinations.

Travellers' vaccine hesitation:

can affect the uptake of travel vaccinations, much like overall vaccination patterns. Some people may choose not to receive recommended immunisations due to worries about vaccine efficacy, safety, or perceived necessity.

Logistical Difficulties:

Travellers, particularly those with complicated itineraries or little time left before departure, may encounter logistical difficulties when administering travel vaccinations, which frequently call for several doses spread over a set period of time.

Complexity of Travel Itineraries:

It may be difficult for travellers with complex itineraries, which include trips to several locations with various vaccine needs, to navigate and comply with all prescribed vaccinations, which could result in missed or insufficient vaccinations.

Short-Term Travel:

People who take short vacations or leave early may put other travel-related plans ahead of getting vaccinated against disease, particularly if they believe their risk of illness is minimal.

Regulatory Barriers:

Travellers may encounter difficulties if they are unable to receive the necessary vaccines in a timely manner. Examples of regulatory barriers include visa requirements and entry restrictions based on vaccination status.

Lack of Education and Awareness:

There may be a low demand for vaccinations due to travellers' ignorance of the value of travel immunisations and the dangers of vaccine-preventable diseases in certain locations.

Competing Priorities:

If a traveller believes there is little chance of catching a vaccine-preventable disease or if they don't have enough time or money for pre-travel medical treatment, they may place a higher priority on other travel-related costs or preparations than getting vaccinated.

Outbreaks and Travel Concerns:

Although infectious disease outbreaks can increase demand for some travel vaccinations, they can also discourage travel altogether, which lowers demand for travel vaccinations generally during such times.

Global Travel Vaccines Market Segmentation Analysis

The Global Travel Vaccines Market is segmented on the basis of Product, Application, And Geography.

Travel Vaccines Market, By Product

• Meningococcal Vaccines
• Hepatitis B Vaccines
• Hepatitis A Vaccines
• Others

Based on Product, the market is bifurcated into Meningococcal Vaccines, Hepatitis B Vaccines, Hepatitis A Vaccines, and Others. Hepatitis A is the disease that affects people the most frequently. It is a virus that can be contracted through direct contact with an infected person or through contaminated food or water.

Travel Vaccines Market, By Application

• Domestic Travel
• Outbound Travel

Based on Application, the market is bifurcated into Domestic Travel and Outbound Travel. The outbound Travel segment dominated the market with the largest share in 2019. A trip that is outbound involves traveling abroad. The main difference is that it is done in a different nation and also includes sightseeing and touring. Many travel companies arrange excursions outside of their home countries. Additionally, domestic travel fundamentally refers to intercity travel within the same nation. Domestic air travel differs significantly from international air travel in that customs and immigration procedures are typically more streamlined and lax. Additionally, domestic services may provide fewer offerings and extras than foreign services.

Travel Vaccines Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Regional Analysis, the Global Travel Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The United States is predicted to dominate the market for human immunizations in North America. In North America, the segments for attenuated and recombinant vaccines are projected to expand more quickly than the ones for combination vaccinations. In terms of product, the Travel Vaccines Market is expected to expand quickly. Increased vaccination demand and rising R&D spending are driving growth in the European market for traveler's vaccines.
• Asia Pacific is a booming market for travel vaccines because of the region's improving healthcare infrastructure and rising government investment in education and awareness programs. The market for travel vaccines is expanding as a result of the development of the healthcare system and the economies of the Middle East and Africa. However, there are barriers preventing the market from expanding, including accessibility concerns and a lack of patient education. There is a market opportunity for travel vaccines given that the Saudi Arabian government regularly conducts immunization campaigns for the flu, influenza, and other diseases.

Key Players

• The "Global Travel Vaccines Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
• Pfizer, Sanofi, GlaxoSmithKline, Merck, AstraZeneca, Abbott, Roche, Takeda Pharmaceutical, Valeant Pharmaceuticals, SK Chemicals, Hualan Biological Engineering, Serum Institute of India.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight to the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1. Introduction of Global Travel Vaccines Market

• Overview of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Travel Vaccines Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Travel Vaccines Market, By Product

• Meningococcal Vaccines
• Hepatitis B Vaccines
• Hepatitis A Vaccines
• Others

6. Global Travel Vaccines Market, By Application

• Domestic Travel
• Outbound Travel

7. Global Travel Vaccines Market, By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

8. Global Travel Vaccines Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

9. Company Profiles

• Pfizer
• Sanofi
• GlaxoSmithKline
• Merck
• AstraZeneca
• Abbott
• Roche
• Takeda Pharmaceutical
• Valeant Pharmaceuticals
• SK Chemicals
• Hualan Biological Engineering
• Serum Institute of India

10. Appendix

• Related Research